Tel:
Email:

Phosphoramidites

2'-Modified Phosphoramidites
(549/549)
2'-Phosphoramidites
(27/27)
3'-Modified Phosphoramidites
(201/201)
5'-Modified Phosphoramidites
(34/34)
Arabino Phosphoramidites
(24/24)
Base Protected Phosphoramidites (435/435) Dye Phosphoramidites
(63/63)
Label Phosphoramidites
(81/81)
Linker Phosphoramidites
(97/97)
Other Phosphoramidites
(94/94)
PMO Phosphoramidates and Derivatives (33/33) PseudoUridine Phosphoramidite
(12/12)
Reverse Phosphoramidites
(25/25)
Spacer Phosphoramidites
(24/24)
Backbone
Modification
Base Type
Filtered by
Clear All

DMO-4AA-N,N-dimethyl phosphoramidochloridate

Description: DMO-4AA-N,N-dimethyl phosphoramidochloridate is a reagent used in oligonucleotide synthesis. It features a 4-amino group on the nucleobase and a dimethyl phosphoramidochloridate group, facilitating the introduction of specific phosphoramidite functionalities. This enhances the chemical stability and hybridization properties of the synthesized oligonucleotides, making it valuable for research and therapeutic applications.
CAT: BRP-01139
Molecular Formula: C57H59ClN14O8P2
Molecular Weight: 1165.59
Purity: ≥95% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: DFGOMKBKDOPFFZ-OJYZEZLKSA-N
IUPAC Name: ((2S,6R)-6-(6-benzamido-9H-purin-9-yl)-4-((((2S,6R)-6-(6-benzamido-9H-purin-9-yl)-4-tritylmorpholin-2-yl)methoxy)(dimethylamino)phosphoryl)morpholin-2-yl)methyl dimethylphosphoramidochloridate
InChI: InChI=1S/C57H59ClN14O8P2/c1-67(2)81(58,75)77-34-46-31-70(33-48(80-46)72-39-64-50-52(60-37-62-54(50)72)66-56(74)41-22-12-6-13-23-41)82(76,68(3)4)78-35-45-30-69(57(42-24-14-7-15-25-42,43-26-16-8-17-27-43)44-28-18-9-19-29-44)32-47(79-45)71-38-63-49-51(59-36-61-53(49)71)65-55(73)40-20-10-5-11-21-40/h5-29,36-39,45-48H,30-35H2,1-4H3,(H,59,61,65,73)(H,60,62,66,74)/t45-,46-,47+,48+,81?,82?/m0/s1
Synonyms: DMO-4A(Bz)A(Bz)-N,N-dimethyl phosphoramidochloridate

DMO-4CA-N,N-dimethyl phosphoramidochloridate

Description: DMO-4CA-N,N-dimethyl phosphoramidochloridate is a reagent employed in oligonucleotide synthesis. It contains a 4-amino group on the cytosine nucleobase and a dimethyl phosphoramidochloridate group, allowing for the introduction of specific phosphoramidite functionalities. This enhances the stability and binding properties of the resulting oligonucleotides, making it useful for various research and therapeutic applications.
CAT: BRP-01140
Molecular Formula: C56H59ClN12O9P2
Molecular Weight: 1141.56
Purity: ≥95% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: VVSWCOAQQJYWEF-INJDICEFSA-N
IUPAC Name: ((2S,6R)-6-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-4-((((2S,6R)-6-(6-benzamido-9H-purin-9-yl)-4-tritylmorpholin-2-yl)methoxy)(dimethylamino)phosphoryl)morpholin-2-yl)methyl dimethylphosphoramidochloridate
InChI: InChI=1S/C56H59ClN12O9P2/c1-64(2)79(57,73)75-36-46-33-67(35-49(78-46)68-31-30-47(62-55(68)72)61-53(70)40-20-10-5-11-21-40)80(74,65(3)4)76-37-45-32-66(56(42-24-14-7-15-25-42,43-26-16-8-17-27-43)44-28-18-9-19-29-44)34-48(77-45)69-39-60-50-51(58-38-59-52(50)69)63-54(71)41-22-12-6-13-23-41/h5-31,38-39,45-46,48-49H,32-37H2,1-4H3,(H,58,59,63,71)(H,61,62,70,72)/t45-,46-,48+,49+,79?,80?/m0/s1
Synonyms: DMO-4C(Bz)A(Bz)-N,N-dimethyl phosphoramidochloridate

DMO-4CC-N,N-dimethyl phosphoramidochloridate

Description: DMO-4CC-N,N-dimethyl phosphoramidochloridate is a reagent used in oligonucleotide synthesis, featuring a 4-amino group on the cytosine nucleobase and a dimethyl phosphoramidochloridate group. It enables the introduction of specific phosphoramidite functionalities, enhancing the stability and binding affinity of the synthesized oligonucleotides. This reagent is valuable for research and therapeutic applications in nucleic acid chemistry.
CAT: BRP-01141
Molecular Formula: C55H59ClN10O10P2
Molecular Weight: 1117.52
Purity: ≥95% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: AJXQYLRIFMQLHF-XWKZHAFPSA-N
IUPAC Name: ((2S,6R)-6-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-4-((((2S,6R)-6-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methoxy)(dimethylamino)phosphoryl)morpholin-2-yl)methyl dimethylphosphoramidochloridate
InChI: InChI=1S/C55H59ClN10O10P2/c1-61(2)77(56,71)73-38-46-35-64(37-50(76-46)66-33-31-48(60-54(66)70)58-52(68)41-22-12-6-13-23-41)78(72,62(3)4)74-39-45-34-63(36-49(75-45)65-32-30-47(59-53(65)69)57-51(67)40-20-10-5-11-21-40)55(42-24-14-7-15-25-42,43-26-16-8-17-27-43)44-28-18-9-19-29-44/h5-33,45-46,49-50H,34-39H2,1-4H3,(H,57,59,67,69)(H,58,60,68,70)/t45-,46-,49+,50+,77?,78?/m0/s1
Synonyms: DMO-4C(Bz)C(Bz)-N,N-dimethyl phosphoramidochloridate

DMO-4AC-N,N-dimethyl phosphoramidochloridate

Description: DMO-4AC-N,N-dimethyl phosphoramidochloridate is a reagent used in oligonucleotide synthesis. It contains a 4-amino group on the adenine nucleobase and a dimethyl phosphoramidochloridate group, allowing for the introduction of specific phosphoramidite functionalities. This enhances the stability, binding affinity, and overall performance of the resulting oligonucleotides, making it valuable for research and therapeutic applications.
CAT: BRP-01142
Molecular Formula: C56H59ClN12O9P2
Molecular Weight: 1141.56
Purity: ≥95% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: MGRBUUDLZWZYSJ-INJDICEFSA-N
IUPAC Name: ((2S,6R)-4-((((2S,6R)-6-(4-benzamido-2-oxopyrimidin-1(2H)-yl)-4-tritylmorpholin-2-yl)methoxy)(dimethylamino)phosphoryl)-6-(6-benzamido-9H-purin-9-yl)morpholin-2-yl)methyl dimethylphosphoramidochloridate
InChI: InChI=1S/C56H59ClN12O9P2/c1-64(2)79(57,73)75-36-46-33-67(35-49(78-46)69-39-60-50-51(58-38-59-52(50)69)63-54(71)41-22-12-6-13-23-41)80(74,65(3)4)76-37-45-32-66(34-48(77-45)68-31-30-47(62-55(68)72)61-53(70)40-20-10-5-11-21-40)56(42-24-14-7-15-25-42,43-26-16-8-17-27-43)44-28-18-9-19-29-44/h5-31,38-39,45-46,48-49H,32-37H2,1-4H3,(H,58,59,63,71)(H,61,62,70,72)/t45-,46-,48+,49+,79?,80?/m0/s1
Synonyms: DMO-4A(Bz)C(Bz)-N,N-dimethyl phosphoramidochloridate

[5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It contains a 5'-O-DMTr-2'-OMe-adenosine with a benzoyl (Bz) protecting group, coupled with a 2'-O-Me-guanosine featuring an isobutyryl (iBu) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01143
Molecular Formula: C66H77N13O16P2
Molecular Weight: 1370.36
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: VVYUEZXTVXFAIS-LLYQIHFBSA-N
IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C66H77N13O16P2/c1-40(2)60(80)75-65-74-59-52(62(82)76-65)72-39-78(59)63-55(86-9)53(94-96(89-33-17-31-67)79(41(3)4)42(5)6)50(93-63)36-91-97(83,90-34-18-32-68)95-54-49(92-64(56(54)87-10)77-38-71-51-57(69-37-70-58(51)77)73-61(81)43-19-13-11-14-20-43)35-88-66(44-21-15-12-16-22-44,45-23-27-47(84-7)28-24-45)46-25-29-48(85-8)30-26-46/h11-16,19-30,37-42,49-50,53-56,63-64H,17-18,33-36H2,1-10H3,(H,69,70,73,81)(H2,74,75,76,80,82)/t49-,50-,53-,54-,55-,56-,63-,64-,96?,97?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-A(benzoyl)](pCyEt)[2'-O-Me-G(isobutyryl)-3'-cyanoethyl-Phosphoramidite]

[5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-O-Me-U-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-O-Me-U-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It features a 5'-O-DMTr-2'-OMe-guanosine with an isobutyryl (iBu) protecting group, coupled with a 2'-O-Me-uridine. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01144
Molecular Formula: C58H72N10O17P2
Molecular Weight: 1243.21
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: KJCRHKCTDIUGLT-DEECTFEXSA-N
IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C58H72N10O17P2/c1-35(2)52(70)64-56-63-51-46(53(71)65-56)61-34-67(51)55-50(77-10)48(43(82-55)32-78-58(38-16-12-11-13-17-38,39-18-22-41(74-7)23-19-39)40-20-24-42(75-8)25-21-40)85-87(73,80-31-15-28-60)81-33-44-47(84-86(79-30-14-27-59)68(36(3)4)37(5)6)49(76-9)54(83-44)66-29-26-45(69)62-57(66)72/h11-13,16-26,29,34-37,43-44,47-50,54-55H,14-15,30-33H2,1-10H3,(H,62,69,72)(H2,63,64,65,70,71)/t43-,44-,47-,48-,49-,50-,54-,55-,86?,87?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-G(isobutyryl)](pCyEt)[2'-O-Me-U-3'-cyanoethyl-Phosphoramidite]; GmUm; [5'-O-DMTr-2'-OMe-G(ibu)](pCyEt)[2'-OMe-U-3'-CE-Phosphoramidite]

[5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-O-Me-C(Ac)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-O-Me-C(Ac)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-adenosine with a benzoyl (Bz) protecting group, coupled with a 2'-O-Me-cytidine featuring an acetyl (Ac) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01145
Molecular Formula: C63H73N11O16P2
Molecular Weight: 1302.29
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: BRZMOTWQGIPHRX-ZXQRUMROSA-N
IUPAC Name: (2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-2-((((((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C63H73N11O16P2/c1-40(2)74(41(3)4)91(84-34-16-31-64)89-53-50(88-60(55(53)81-8)72-33-30-51(69-42(5)75)70-62(72)77)37-86-92(78,85-35-17-32-65)90-54-49(87-61(56(54)82-9)73-39-68-52-57(66-38-67-58(52)73)71-59(76)43-18-12-10-13-19-43)36-83-63(44-20-14-11-15-21-44,45-22-26-47(79-6)27-23-45)46-24-28-48(80-7)29-25-46/h10-15,18-30,33,38-41,49-50,53-56,60-61H,16-17,34-37H2,1-9H3,(H,66,67,71,76)(H,69,70,75,77)/t49-,50-,53-,54-,55-,56-,60-,61-,91?,92?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-A(benzoyl)](pCyEt)[2'-O-Me-C(acetyl)-3'-cyanoethyl-Phosphoramidite]

[5'-O-DMTr-2'-OMe-C(Ac)](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-C(Ac)](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-cytidine with an acetyl (Ac) protecting group, coupled with a 2'-O-Me-adenosine featuring a benzoyl (Bz) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01146
Molecular Formula: C63H73N11O16P2
Molecular Weight: 1302.29
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: SPTHDVXNFLLFJO-ZXQRUMROSA-N
IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(6-benzamido-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C63H73N11O16P2/c1-40(2)74(41(3)4)91(84-34-16-31-64)89-53-50(88-61(55(53)81-8)73-39-68-52-57(66-38-67-58(52)73)71-59(76)43-18-12-10-13-19-43)37-86-92(78,85-35-17-32-65)90-54-49(87-60(56(54)82-9)72-33-30-51(69-42(5)75)70-62(72)77)36-83-63(44-20-14-11-15-21-44,45-22-26-47(79-6)27-23-45)46-24-28-48(80-7)29-25-46/h10-15,18-30,33,38-41,49-50,53-56,60-61H,16-17,34-37H2,1-9H3,(H,66,67,71,76)(H,69,70,75,77)/t49-,50-,53-,54-,55-,56-,60-,61-,91?,92?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-C(acetyl)](pCyEt)[2'-O-methyl-A(benzoyl)-3'-cyanoethyl-Phosphoramidite]

[5'-O-DMTr-2'-OMe-U](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-U](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It contains a 5'-O-DMTr-2'-OMe-uridine, coupled with a 2'-O-Me-adenosine featuring a benzoyl (Bz) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01147
Molecular Formula: C61H70N10O16P2
Molecular Weight: 1261.23
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: ASHCZTKKWZMQOE-DNSVLMGFSA-N
IUPAC Name: (2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C61H70N10O16P2/c1-39(2)71(40(3)4)88(81-33-15-30-62)86-51-48(85-59(53(51)78-7)70-38-66-50-55(64-37-65-56(50)70)68-57(73)41-17-11-9-12-18-41)36-83-89(75,82-34-16-31-63)87-52-47(84-58(54(52)79-8)69-32-29-49(72)67-60(69)74)35-80-61(42-19-13-10-14-20-42,43-21-25-45(76-5)26-22-43)44-23-27-46(77-6)28-24-44/h9-14,17-29,32,37-40,47-48,51-54,58-59H,15-16,33-36H2,1-8H3,(H,67,72,74)(H,64,65,68,73)/t47-,48-,51-,52-,53-,54-,58-,59-,88?,89?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-U](pCyEt)[5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-A(benzoyl)-3'-cyanoethyl-Phosphoramidite]; [5'-O-DMTr-2'-OMe-U](pCyEt)[5'-O-DMTr-2'-OMe-A(Bz)-3'-CE-Phosphoramidite]

[5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-guanosine with an isobutyryl (iBu) protecting group, coupled with a 2'-O-Me-adenosine featuring a benzoyl (Bz) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01148
Molecular Formula: C66H77N13O16P2
Molecular Weight: 1370.36
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: VTDGJORSPBHICB-LLYQIHFBSA-N
IUPAC Name: (2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C66H77N13O16P2/c1-40(2)60(80)75-65-74-59-52(62(82)76-65)72-39-78(59)64-56(87-10)54(49(92-64)35-88-66(44-21-15-12-16-22-44,45-23-27-47(84-7)28-24-45)46-25-29-48(85-8)30-26-46)95-97(83,90-34-18-32-68)91-36-50-53(94-96(89-33-17-31-67)79(41(3)4)42(5)6)55(86-9)63(93-50)77-38-71-51-57(69-37-70-58(51)77)73-61(81)43-19-13-11-14-20-43/h11-16,19-30,37-42,49-50,53-56,63-64H,17-18,33-36H2,1-10H3,(H,69,70,73,81)(H2,74,75,76,80,82)/t49-,50-,53-,54-,55-,56-,63-,64-,96?,97?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-G(isobutyryl)](pCyEt)[2'-O-methyl-A(benzoyl)-3'-cyanoethyl-Phosphoramidite]

[5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-OMe-C(Ac)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-OMe-C(Ac)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-guanosine with an isobutyryl (iBu) protecting group, coupled with a 2'-O-Me-cytidine featuring an acetyl (Ac) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01149
Molecular Formula: C60H75N11O17P2
Molecular Weight: 1284.27
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: RBAOMSBFWCYTRH-UWSVYRINSA-N
IUPAC Name: (2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-2-((((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C60H75N11O17P2/c1-36(2)54(73)67-58-66-53-48(55(74)68-58)63-35-70(53)57-52(80-11)50(45(85-57)33-81-60(40-17-13-12-14-18-40,41-19-23-43(77-8)24-20-41)42-21-25-44(78-9)26-22-42)88-90(76,83-32-16-29-62)84-34-46-49(87-89(82-31-15-28-61)71(37(3)4)38(5)6)51(79-10)56(86-46)69-30-27-47(64-39(7)72)65-59(69)75/h12-14,17-27,30,35-38,45-46,49-52,56-57H,15-16,31-34H2,1-11H3,(H,64,65,72,75)(H2,66,67,68,73,74)/t45-,46-,49-,50-,51-,52-,56-,57-,89?,90?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-G(isobutyryl)](pCyEt)[2'-O-methyl-C(acetyl)-3'-cyanoethyl-Phosphoramidite]

[5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-OMe-A(Bz)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-adenosine with a benzoyl (Bz) protecting group, coupled with a 2'-O-Me-adenosine also featuring a benzoyl (Bz) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01150
Molecular Formula: C69H75N13O15P2
Molecular Weight: 1388.38
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: DKVYWLXZDOXBOR-VVBNRIDZSA-N
IUPAC Name: (2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((((((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C69H75N13O15P2/c1-44(2)82(45(3)4)98(91-36-18-34-70)96-57-54(95-67(59(57)88-7)80-42-76-55-61(72-40-74-63(55)80)78-65(83)46-20-12-9-13-21-46)39-93-99(85,92-37-19-35-71)97-58-53(94-68(60(58)89-8)81-43-77-56-62(73-41-75-64(56)81)79-66(84)47-22-14-10-15-23-47)38-90-69(48-24-16-11-17-25-48,49-26-30-51(86-5)31-27-49)50-28-32-52(87-6)33-29-50/h9-17,20-33,40-45,53-54,57-60,67-68H,18-19,36-39H2,1-8H3,(H,72,74,78,83)(H,73,75,79,84)/t53-,54-,57-,58-,59-,60-,67-,68-,98?,99?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-A(benzoyl)](pCyEt)[2'-O-methyl-A(benzoyl)-3'-cyanoethyl-Phosphoramidite]

[5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-O-Me-U-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-A(Bz)](pCyEt)[2'-O-Me-U-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-adenosine with a benzoyl (Bz) protecting group, coupled with a 2'-O-Me-uridine. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01151
Molecular Formula: C61H70N10O16P2
Molecular Weight: 1261.23
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: AKASCWHWFRSDPA-DNSVLMGFSA-N
IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C61H70N10O16P2/c1-39(2)71(40(3)4)88(81-33-15-30-62)86-51-48(85-58(53(51)78-7)69-32-29-49(72)67-60(69)74)36-83-89(75,82-34-16-31-63)87-52-47(84-59(54(52)79-8)70-38-66-50-55(64-37-65-56(50)70)68-57(73)41-17-11-9-12-18-41)35-80-61(42-19-13-10-14-20-42,43-21-25-45(76-5)26-22-43)44-23-27-46(77-6)28-24-44/h9-14,17-29,32,37-40,47-48,51-54,58-59H,15-16,33-36H2,1-8H3,(H,67,72,74)(H,64,65,68,73)/t47-,48-,51-,52-,53-,54-,58-,59-,88?,89?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-A(benzoyl)](pCyEt)[2'-O-Me-U-3'-cyanoethyl-Phosphoramidite]; AmUm; [5'-O-DMTr-2'-OMe-dA(Bz)](pCyEt)[2'-OMe-U-3'-CE-Phosphoramidite]

[5'-O-DMTr-2'-OMe-U](pCyEt)[2'-O-Me-U-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-U](pCyEt)[2'-O-Me-U-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-uridine, coupled with a 2'-O-Me-uridine. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01152
Molecular Formula: C53H65N7O17P2
Molecular Weight: 1134.08
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: SGCPCDCDFYMHHQ-SXOXBGJYSA-N
IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C53H65N7O17P2/c1-34(2)60(35(3)4)78(71-30-12-26-54)76-45-42(75-49(47(45)68-7)58-28-24-43(61)56-51(58)63)33-73-79(65,72-31-13-27-55)77-46-41(74-50(48(46)69-8)59-29-25-44(62)57-52(59)64)32-70-53(36-14-10-9-11-15-36,37-16-20-39(66-5)21-17-37)38-18-22-40(67-6)23-19-38/h9-11,14-25,28-29,34-35,41-42,45-50H,12-13,30-33H2,1-8H3,(H,56,61,63)(H,57,62,64)/t41-,42-,45-,46-,47-,48-,49-,50-,78?,79?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-U](pCyEt)[2'-O-Me-U-3'-cyanoethyl-Phosphoramidite]; UmUm; [5'-O-DMTr-2'-OMe-U](pCyEt)[2'-OMe-U-3'-CE Phosphoramidite]

[5'-O-DMTr-2'-OMe-C(Ac)](pCyEt)[2'-O-Me-U-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-C(Ac)](pCyEt)[2'-O-Me-U-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-cytidine with an acetyl (Ac) protecting group, coupled with a 2'-O-Me-uridine. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01153
Molecular Formula: C55H68N8O17P2
Molecular Weight: 1175.14
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: DBULUINHIAJRPG-AQFWJGNWSA-N
IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C55H68N8O17P2/c1-35(2)63(36(3)4)81(74-31-13-27-56)79-47-44(78-51(49(47)71-8)62-30-26-46(65)60-54(62)67)34-76-82(68,75-32-14-28-57)80-48-43(77-52(50(48)72-9)61-29-25-45(58-37(5)64)59-53(61)66)33-73-55(38-15-11-10-12-16-38,39-17-21-41(69-6)22-18-39)40-19-23-42(70-7)24-20-40/h10-12,15-26,29-30,35-36,43-44,47-52H,13-14,31-34H2,1-9H3,(H,60,65,67)(H,58,59,64,66)/t43-,44-,47-,48-,49-,50-,51-,52-,81?,82?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-C(acetyl)](pCyEt)[2'-O-Me-U-3'-cyanoethyl-Phosphoramidite]; CmUm; [5'-O-DMTr-2'-OMe-C(Ac)](pCyEt)[2'-OMe-U-3'-CE Phosphoramidite]

[5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-guanosine with an isobutyryl (iBu) protecting group, coupled with a 2'-O-Me-guanosine also featuring an isobutyryl (iBu) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01154
Molecular Formula: C63H79N13O17P2
Molecular Weight: 1352.35
Purity: ≥95% by HPLC
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: MSQJFSFYPIFAMO-XXECTENDSA-N
IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C63H79N13O17P2/c1-36(2)55(77)70-61-68-53-47(57(79)72-61)66-34-74(53)59-51(84-11)49(92-94(87-30-16-28-64)76(38(5)6)39(7)8)46(91-59)33-89-95(81,88-31-17-29-65)93-50-45(90-60(52(50)85-12)75-35-67-48-54(75)69-62(73-58(48)80)71-56(78)37(3)4)32-86-63(40-18-14-13-15-19-40,41-20-24-43(82-9)25-21-41)42-22-26-44(83-10)27-23-42/h13-15,18-27,34-39,45-46,49-52,59-60H,16-17,30-33H2,1-12H3,(H2,68,70,72,77,79)(H2,69,71,73,78,80)/t45-,46-,49-,50-,51-,52-,59-,60-,94?,95?/m1/s1
Synonyms: [5'-O-DMTr-2'-OMe-G(iBu)](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite]

[5'-O-DMTr-2'-OMe-U](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-U](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-uridine, coupled with a 2'-O-Me-guanosine featuring an isobutyryl (iBu) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01155
Molecular Formula: C58H72N10O17P2
Molecular Weight: 1243.21
Purity: ≥95% by HPLC
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: PJSNGMFTSNHPEB-DEECTFEXSA-N
IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-5-(2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C58H72N10O17P2/c1-35(2)52(70)64-56-63-51-46(53(71)65-56)61-34-67(51)55-49(76-9)47(84-86(79-30-14-27-59)68(36(3)4)37(5)6)44(83-55)33-81-87(73,80-31-15-28-60)85-48-43(82-54(50(48)77-10)66-29-26-45(69)62-57(66)72)32-78-58(38-16-12-11-13-17-38,39-18-22-41(74-7)23-19-39)40-20-24-42(75-8)25-21-40/h11-13,16-26,29,34-37,43-44,47-50,54-55H,14-15,30-33H2,1-10H3,(H,62,69,72)(H2,63,64,65,70,71)/t43-,44-,47-,48-,49-,50-,54-,55-,86?,87?/m1/s1
Synonyms: [5'-O-DMTr-2'-OMe-U](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite]

[5'-O-DMTr-2'-OMe-C(Ac)](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-C(Ac)](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-cytidine with an acetyl (Ac) protecting group, coupled with a 2'-O-Me-guanosine featuring an isobutyryl (iBu) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01156
Molecular Formula: C60H75N11O17P2
Molecular Weight: 1284.27
Purity: ≥95% by HPLC
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: JREOEYAVHNOKMM-UWSVYRINSA-N
IUPAC Name: (2R,3R,4R,5R)-2-((((((2R,3R,4R,5R)-5-(4-acetamido-2-oxopyrimidin-1(2H)-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-5-(2-isobutyramido-6-oxo-1,6-dihydro-9H-purin-9-yl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C60H75N11O17P2/c1-36(2)54(73)67-58-66-53-48(55(74)68-58)63-35-70(53)57-51(79-10)49(87-89(82-31-15-28-61)71(37(3)4)38(5)6)46(86-57)34-84-90(76,83-32-16-29-62)88-50-45(85-56(52(50)80-11)69-30-27-47(64-39(7)72)65-59(69)75)33-81-60(40-17-13-12-14-18-40,41-19-23-43(77-8)24-20-41)42-21-25-44(78-9)26-22-42/h12-14,17-27,30,35-38,45-46,49-52,56-57H,15-16,31-34H2,1-11H3,(H,64,65,72,75)(H2,66,67,68,73,74)/t45-,46-,49-,50-,51-,52-,56-,57-,89?,90?/m1/s1
Synonyms: [5'-O-DMTr-2'-OMe-C(Ac)](pCyEt)[2'-O-Me-G(iBu)-3'-CE-Phosphoramidite]

[5'-O-DMTr-2'-OMe-A(Bz)](P-thio-pCyEt) [2'-O-Me-A(Bz)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-A(Bz)](P-thio-pCyEt) [2'-O-Me-A(Bz)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-adenosine with a benzoyl (Bz) protecting group, coupled with a 2'-O-Me-adenosine also featuring a benzoyl (Bz) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01157
Molecular Formula: C69H75N13O14P2S
Molecular Weight: 1404.44
Purity: ≥97% by HPLC
Appearance: White, off-white to faint yellow powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: XCGJIPXEZUXVNV-YKUGJANUSA-N
CanonicalSMILES: N#CCCOP(OC1C(OC(N2C=NC=3C(=NC=NC32)NC(=O)C=4C=CC=CC4)C1OC)COP(=S)(OCCC#N)OC5C(OC(N6C=NC=7C(=NC=NC76)NC(=O)C=8C=CC=CC8)C5OC)COC(C=9C=CC=CC9)(C%10=CC=C(OC)C=C%10)C%11=CC=C(OC)C=C%11)N(C(C)C)C(C)C
IUPAC Name: (2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((((((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphorothioyl)oxy)methyl)-4-methoxytetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C69H75N13O14P2S/c1-44(2)82(45(3)4)97(90-36-18-34-70)95-57-54(94-67(59(57)87-7)80-42-76-55-61(72-40-74-63(55)80)78-65(83)46-20-12-9-13-21-46)39-92-98(99,91-37-19-35-71)96-58-53(93-68(60(58)88-8)81-43-77-56-62(73-41-75-64(56)81)79-66(84)47-22-14-10-15-23-47)38-89-69(48-24-16-11-17-25-48,49-26-30-51(85-5)31-27-49)50-28-32-52(86-6)33-29-50/h9-17,20-33,40-45,53-54,57-60,67-68H,18-19,36-39H2,1-8H3,(H,72,74,78,83)(H,73,75,79,84)/t53-,54-,57-,58-,59-,60-,67-,68-,97?,98?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-A(benzoyl)](P-thio-pCyEt) [2'-O-Me-A(benzoyl)-3'-cyanoethyl-Phosphoramidite]

[5'-O-DMTr-2'-OMe-A(Bz)](pCyEt) [2'-F-dA(Bz)-3'-CE-Phosphoramidite]

Description: [5'-O-DMTr-2'-OMe-A(Bz)](pCyEt) [2'-F-dA(Bz)-3'-CE-Phosphoramidite] is a modified nucleoside phosphoramidite used in oligonucleotide synthesis. It consists of a 5'-O-DMTr-2'-OMe-adenosine with a benzoyl (Bz) protecting group, coupled with a 2'-fluoro-deoxyadenosine (2'-F-dA) also featuring a benzoyl (Bz) protecting group. These modifications enhance the stability, binding specificity, and resistance to enzymatic degradation of the resulting oligonucleotides, making it valuable for biochemical research and therapeutic applications.
CAT: BRP-01158
Molecular Formula: C68H72FN13O14P2
Molecular Weight: 1376.35
Purity: ≥95% by HPLC
Appearance: White to off-white powder
Size Price Stock Quantity
-- -- --
Inquiry   
Storage: Store at -20 °C
InChIKey: XJSBJPLHTAATIR-YKZUEJCGSA-N
IUPAC Name: (2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((((((2R,3R,4R,5R)-5-(6-benzamido-9H-purin-9-yl)-2-((bis(4-methoxyphenyl)(phenyl)methoxy)methyl)-4-methoxytetrahydrofuran-3-yl)oxy)(2-cyanoethoxy)phosphoryl)oxy)methyl)-4-fluorotetrahydrofuran-3-yl (2-cyanoethyl) diisopropylphosphoramidite
InChI: InChI=1S/C68H72FN13O14P2/c1-43(2)82(44(3)4)97(90-35-17-33-70)95-57-53(93-66(54(57)69)80-41-76-55-60(72-39-74-62(55)80)78-64(83)45-19-11-8-12-20-45)38-92-98(85,91-36-18-34-71)96-58-52(94-67(59(58)88-7)81-42-77-56-61(73-40-75-63(56)81)79-65(84)46-21-13-9-14-22-46)37-89-68(47-23-15-10-16-24-47,48-25-29-50(86-5)30-26-48)49-27-31-51(87-6)32-28-49/h8-16,19-32,39-44,52-54,57-59,66-67H,17-18,35-38H2,1-7H3,(H,72,74,78,83)(H,73,75,79,84)/t52-,53-,54-,57-,58-,59-,66-,67-,97?,98?/m1/s1
Synonyms: [5'-O-(4,4'-dimethoxytrityl)-2'-O-methyl-A(benzoyl)](pCyEt)[2'-Fluoro-dA(benzoyl)-3'-cyanoethyl-Phosphoramidite]

Frequently Asked Questions (FAQ)

What are phosphoramidites used for?

Phosphoramidites are activated monomers used in solid-phase DNA and RNA oligonucleotide synthesis.

What is the difference between DNA and RNA phosphoramidites?

RNA phosphoramidites include additional 2′-hydroxyl protecting groups, making them more sensitive to moisture and handling conditions.

Why is moisture control important for phosphoramidites?

Moisture can cause premature hydrolysis of phosphoramidites, reducing coupling efficiency and synthesis yield.

Can phosphoramidites be used for long oligonucleotide synthesis?

Yes, high-quality phosphoramidites are essential for achieving good yields in long and complex oligonucleotide sequences.

Are modified phosphoramidites available for custom oligos?

Modified and specialty phosphoramidites are commonly used to introduce functional groups or labels into oligonucleotides.

* Only for research. Not suitable for any diagnostic or therapeutic use.

Our Products

Online Inquiry
Verification code
Inquiry Basket